UTMB to enroll first patient in US trial of brain tumor imaging technology August 27, 2026 • 9:53 a.m. by Margaret Battistelli Gardner Investigational agent makes cancerous tissue light up during surgery, potentially helping neurosurgeons distinguish tumors from healthy brain tissue. UTMB launches fellowship to prepare physicians for medicine from the ocean floor to outer space August 14, 2026 • 12:00 p.m. by Margaret Battistelli Gardner New Undersea and Hyperbaric Medicine Fellowship will train doctors to care for patients in exploration environments as human spaceflight continues to expand. UTMB study finds a form of inflammation that current diabetes and heart treatments do not reach August 14, 2026 • 7:42 a.m. by Staff A UTMB-led study found that people with Type 2 diabetes may remain at increased risk for heart attack, stroke, and death despite treatment. Elevated suPAR levels identified patients with persistent inflammation and higher cardiovascular risk. UTMB research reveals blueprint for longer-lasting vaccines August 12, 2026 • 3:52 p.m. by Margaret Battistelli Gardner New studies identify a vaccine design strategy that strengthens immune memory and could improve protection against HIV, influenza, and other difficult-to-prevent diseases. Rethinking correctional healthcare August 6, 2026 • 8:30 a.m. by Margaret Battistelli Gardner The Center for Correctional Healthcare Excellence at UTMB is advancing research, innovation, education, and clinical care for one of the nation’s most medically vulnerable populations. Strong at any age: UTMB Health strength-training program helps older adults improve health and independence August 5, 2026 • 9:45 a.m. by Margaret Battistelli Gardner Community-based Geri-Fit classes were linked to healthier cholesterol levels, better mobility, and greater independence among older adults. UTMB study shows flea-borne murine typhus can become life-threatening July 31, 2026 • 1:27 p.m. by Margaret Battistelli Gardner Researchers urge early recognition and treatment as murine typhus continues to reemerge along the Texas Gulf Coast. UTMB experimental plague vaccines protect against deadly infection in preclinical study July 28, 2026 • 8:38 a.m. by Margaret Battistelli Gardner The findings suggest the vaccines trigger multiple layers of immune protection and could help advance the development of more effective plague vaccines. UTMB animal research program receives recommendation for continued AAALAC accreditation July 13, 2026 • 9:47 a.m. by Margaret Battistelli Gardner The recommendation follows an extensive site visit in June that evaluated all aspects of the institution's animal research program, including veterinary care, facilities, safety programs, regulatory oversight, and research operations. UTMB study of milder Ebola strain could hold the key to future treatments July 10, 2026 • 8:25 a.m. by Margaret Battistelli Gardner The Bombali strain caused classic Ebola symptoms in laboratory models, yet a full survival rate revealed how the body can fight back. By showing how a less lethal strain can be cleared without fatal organ failure, the findings offer a potential blueprint for future therapies. Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
UTMB to enroll first patient in US trial of brain tumor imaging technology August 27, 2026 • 9:53 a.m. by Margaret Battistelli Gardner Investigational agent makes cancerous tissue light up during surgery, potentially helping neurosurgeons distinguish tumors from healthy brain tissue.
UTMB launches fellowship to prepare physicians for medicine from the ocean floor to outer space August 14, 2026 • 12:00 p.m. by Margaret Battistelli Gardner New Undersea and Hyperbaric Medicine Fellowship will train doctors to care for patients in exploration environments as human spaceflight continues to expand.
UTMB study finds a form of inflammation that current diabetes and heart treatments do not reach August 14, 2026 • 7:42 a.m. by Staff A UTMB-led study found that people with Type 2 diabetes may remain at increased risk for heart attack, stroke, and death despite treatment. Elevated suPAR levels identified patients with persistent inflammation and higher cardiovascular risk.
UTMB research reveals blueprint for longer-lasting vaccines August 12, 2026 • 3:52 p.m. by Margaret Battistelli Gardner New studies identify a vaccine design strategy that strengthens immune memory and could improve protection against HIV, influenza, and other difficult-to-prevent diseases.
Rethinking correctional healthcare August 6, 2026 • 8:30 a.m. by Margaret Battistelli Gardner The Center for Correctional Healthcare Excellence at UTMB is advancing research, innovation, education, and clinical care for one of the nation’s most medically vulnerable populations.
Strong at any age: UTMB Health strength-training program helps older adults improve health and independence August 5, 2026 • 9:45 a.m. by Margaret Battistelli Gardner Community-based Geri-Fit classes were linked to healthier cholesterol levels, better mobility, and greater independence among older adults.
UTMB study shows flea-borne murine typhus can become life-threatening July 31, 2026 • 1:27 p.m. by Margaret Battistelli Gardner Researchers urge early recognition and treatment as murine typhus continues to reemerge along the Texas Gulf Coast.
UTMB experimental plague vaccines protect against deadly infection in preclinical study July 28, 2026 • 8:38 a.m. by Margaret Battistelli Gardner The findings suggest the vaccines trigger multiple layers of immune protection and could help advance the development of more effective plague vaccines.
UTMB animal research program receives recommendation for continued AAALAC accreditation July 13, 2026 • 9:47 a.m. by Margaret Battistelli Gardner The recommendation follows an extensive site visit in June that evaluated all aspects of the institution's animal research program, including veterinary care, facilities, safety programs, regulatory oversight, and research operations.
UTMB study of milder Ebola strain could hold the key to future treatments July 10, 2026 • 8:25 a.m. by Margaret Battistelli Gardner The Bombali strain caused classic Ebola symptoms in laboratory models, yet a full survival rate revealed how the body can fight back. By showing how a less lethal strain can be cleared without fatal organ failure, the findings offer a potential blueprint for future therapies.